On tolerability, retatrutide's GI adverse event rate is higher than tirzepatide's at matched mechanistic dose, which is the tradeoff for the additional mechanism
It is not yet marketed in Spain, where only Ozempic which has the same active ingredient is available, but the latter is financed solely for people with type 2 diabetes
Producto disponible y en stock Detalles del producto Nombre de ventas: Complemento alimenticio -L-Tartrato de carnitina (90 comprimidos) Ingredientes: L- Carnitina, L-Tartrato, agente de recubrimiento (fosfato de calcio, celulosa microcristalina), antiaglomerante (cido esterico, estearato de magnesio, dixido de silicio), agentes de recubrimiento (hidroxipropilmetilcelulosa, glicerina, cera de carnauba)
For me it would be interesting to see if GLP-1s can reduce inflammation and liver damage in other types of liver disease, including fatty liver from a combination of metabolic risk and alcohol consumption (Im guessing a decent fraction of Americans and Britons with fatty liver fall have both of these risk factors)
Wegovy comes in single-use pens, while Ozempic pens contain multiple doses
